Pathogenesis of bacteriuria in women with diabetes mellitus

International Journal of Antimicrobial Agents

Volumn 19, Issue 6, 2002, Pages 539-545

  Geerlings, Suzanne E ^a   Meiland, Ruby ^b   Hoepelman, Andy I M ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Asymptomatic bacteriuria; Diabetes mellitus; Escherichia coli; Urinary tract infection

Indexed keywords

CYTOKINE; GLUCOSE; VIRULENCE FACTOR;

ASYMPTOMATIC BACTERIURIA; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELLULAR IMMUNITY; CONFERENCE PAPER; DIABETES MELLITUS; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GLUCOSURIA; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION RATE; INFECTION RISK; LEUKOCYTE COUNT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; URINARY TRACT INFECTION; BACTERIURIA; IMMUNOLOGY; REVIEW;

BACTERIURIA; DIABETES MELLITUS; FEMALE; HUMAN; URINARY TRACT INFECTIONS; DIABETES COMPLICATIONS; HUMANS;

EID: 0036021492     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00090-0     Document Type: Conference Paper

References (82)

1. Diagnostiek, epidemiologie en prognose
2. Infections in the diabetic patient: Strategies for the clinician
3. Infections and diabetes: Mechanisms and prospects for prevention
4. Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients
5. Infections of the upper urinary tract in the diabetic patient
6. Studies on urinary infection in diabetics. I. Bacteriuria in patients with diabetes mellitus and in control subjects
7. Bacteriuria in diabetic and non-diabetic out-patients
8. Asymptomatic bacteriuria and hemoglobin A1
9. Infection and diabetes mellitus
10. Prevalence of asymptomatic bacteriuria in subjects with NIDDM in San Luis Valley of Colorado
11. Asymptomatic bacteriuria may be considered a complication in women with diabetes
12. Bacterial urinary tract infections in diabetes
13. The treatment of urinary tract infections in women with diabetes mellitus
14. Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria
15. Prevalence and site of bacteriuria in diabetes mellitus
16. Host factors in the pathogenesis of urinary tract infections
17. Urinary tract infections
18. Virulence factors in Escherichia coli urinary tract infection
19. Bacterial virulence in urinary tract infecion
20. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli
21. Pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection
22. Aerobactin and α-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool
23. Urinary tract infection in patients with diabetes mellitus
24. P fimbriae and other virulence factors in Escherichia coli urosepsis: Association with patients' characteristics
25. Virulence factors of Escherichia coli isolated from urine of diabetic women with asymptomatic bacteriuria: Correlation with clinical characteristics
26. Experimental Candida albicans, Staphylococcus aureus, and Streptococcus faecalis pyelonephritis in diabetic rats
27. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: Studies with urine from diabetic and non-diabetic individuals
28. Immune dysfunction in patients with diabetes mellitus (DM)
29. Neutrophil adhesive dysfunction in diabetes mellitus; The role of cellular and plasma factors
30. Impaired leucocyte functions in diabetic patients
31. Polymorphonuclear cell derangements in type I diabetes
32. Granulocyte function in women with diabetes and asymptomatic bacteriuria
33. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus
34. Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients
35. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes
36. Infection in acute leukemia: An analysis of 433 episodes
37. Chemokines-Chemotactic cytokines that mediate inflammation
38. Immunologie in de medische praktijk. VIII. De rol van cytokinen in de pathogenes van bacteriële infecties
39. Tumor necrosis factor: Function, release and clearance
40. Bacterial adherence and mucosal cytokine production
41. Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria
42. Elevated interleukin-8 levels in the urine of patients with urinary tract infections
43. Selective cytokine production by epithelial cells following exposure to Escherichia coli
44. Cytokine- and LPS-induced synthesis of interleukin-8 from human mesangial cells
45. Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro
46. Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defences
47. Changes to the cytokine microenvironmentin the genital tract mucosa of HIV+ women
48. 4+ cell count)
49. Roles of glycoproteins an oligosaccharides found in human vaginal fluid in bacterial adherence
50. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli
51. Tamm-Horsfall Protein inhibits binding of S- and P-fimbriated Escherichia coli to human renal tubular epithelial cells
52. Tamm Horsfall glycoprotein interferes with bacterial adherence to human kidney cells
53. Reduced uromucoid excretion in the elderly
54. Tubular secretion of Tamm-Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy
55. Pronounced decrease of Tamm-Horsfall proteinuria in diabetics
56. Tamm Horsfall glycoprotein in diabetes mellitus: Abnormal chemical composition and colloid stability
57. The relationship between colonisation, secretor status and in-vitro adhesion of Candida albicans to buccal epithelial cells from diabetics
58. Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections
59. Attachment of Escherichia coli to urinary sediment epithelial cells from urinary tract infection-prone and healthy children
60. Bacterial adherence to periurethral epithelial cells in girls prone to urinary-tract infections
61. Adherence of Escherichia coli to uroepithelial cells of diabetic women is increased
62. Cytokine secretion is impaired in women with diabetes mellitus
63. Renal scarring by mannose-sensitive adhesin of Escherichia coli type 1 pili
64. Consequences of asymptomatic bacteriuria in women with diabetes mellitus
65. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract
66. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection
67. Difference in susceptibility to Gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice
68. Neutrophil recruitment and resistance to urinary tract infection
69. Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis
70. Is a second urine necessary for the diagnosis of asymptomatic bacteriuria
71. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women
72. Influence of blood group on the availability of receptors for attachement of uropathogenic Escherichia coli
73. Blood group non-secretors have an increased inflammatory response to urinary tract infection
74. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status
75. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections
76. Natural history of bacteriuria in schoolgirls
77. The natural history of recurrent bacteriuria in schoolgirls
78. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus
79. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections
80. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection
81. Orientation-dependent enhancement by H-NS of the activity of the type 1 fimbrial phase switch promoter in Escherichia coli